BR1400-1

· Boryung Pharmaceutical Co., Ltd

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for BR1400-1, covering 2025-03-21 to 2026-01-28. Get the full timeline:

Most recent: Clinical Trial Update: A Study of BR1400-1, BR1400-2, BR1400-3, BR1400-4, and BR1400-5 in Patients With Essential Hypertension [Phase 2]